Approval · Notice of Compliance 407 · 2002
PROSTASCINT: Notice of Compliance 407
Issued March 8, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 407
- Date
- March 8, 2002
- Company
- Cytogen Corporation
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Radiodiagnostic kit
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROSTASCINT | Not yet assigned | — |
Medicinal ingredients
- CAPROMAB PENDETIDE 0.5 MG per ML